A Phase IA/IB Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Tumors

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Lone Tree Medical Center
University of Colorado Hospital

Study ID

Protocol Number: 17-0991

More information available at ClinicalTrials.gov: NCT03289962

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers